On this basis, it is possible or even likely that NLRC4 inflammasome activity, particularly when augmented by the presence of a particular genetic and/or environmental factor, can make an important contribution to CD-associated inflammation and its inhibition by LRRK2-kinase inhibition plays an important role in its overall ability to treat Crohn’s disease. Here, NLRC4 is linked to Crohn disease.